Th. Gasser

发表

Tissue microarray analysis reveals prognostic significance of syndecan‐1 expression in prostate cancer

L. Bubendorf, E. Gelmann, M. Mihatsch, 2003, The Prostate.

Clinical significance of interobserver differences in the staging and grading of superficial bladder cancer

G. Sauter, T. Gasser, M. Mihatsch, 2000, BJU international.

Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients.

H. Moch, L. Bubendorf, G. Sauter, 2000, Human pathology.

Expression patterns of potential therapeutic targets in prostate cancer

L. Bubendorf, P. Koivisto, M. Mihatsch, 2005, International journal of cancer.

Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression.

O. Kallioniemi, J. Kononen, L. Bubendorf, 2000, Cancer research.

Ki67 LABELLING INDEX: AN INDEPENDENT PREDICTOR OF PROGRESSION IN PROSTATE CANCER TREATED BY RADICAL PROSTATECTOMY

H. Moch, L. Bubendorf, G. Sauter, 1996, The Journal of pathology.

Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays.

E Mahlamäki, T C Gasser, Y. Chen, 1999, Journal of the National Cancer Institute.

Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays.

T C Gasser, H. Moch, O. Kallioniemi, 1999, Cancer research.

Potential consequences of low biopsy core number in selection of patients with prostate cancer for current active surveillance protocols.

L. Bubendorf, C. Rentsch, A. Bachmann, 2013, Urology.

KCNMA1 gene amplification promotes tumor cell proliferation in human prostate cancer

L. Bubendorf, T. Gasser, R. Simon, 2007, Oncogene.

High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma.

H. Moch, O. Kallioniemi, J. Kononen, 1999, The American journal of pathology.

Chromosome 8p deletions are associated with invasive tumor growth in urinary bladder cancer.

F. Waldman, H. Moch, L. Bubendorf, 1997, The American journal of pathology.

High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer.

T Hardmeier, H. Moch, O. Kallioniemi, 2000, The American journal of pathology.

Cyclin D1 overexpression lacks prognostic significance in superficial urinary bladder cancer

H. Moch, G. Sauter, T. Gasser, 1999, The Journal of pathology.

DNA aberrations in urinary bladder cancer detected by flow cytometry and FISH

H. Moch, L. Bubendorf, G. Sauter, 2004, Urological Research.

Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma

H. Moch, G. Sauter, M. Amin, 2000, Cancer.

Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small‐volume or low‐grade prostate cancer

H. Moch, L. Bubendorf, G. Sauter, 2009, International journal of cancer.

Amplification of EIF3S3 gene is associated with advanced stage in prostate cancer.

T. Visakorpi, L. Bubendorf, T. Gasser, 2001, The American journal of pathology.

Chromosomal imbalances in papillary renal cell carcinoma: genetic differences between histological subtypes.

H. Moch, L. Bubendorf, G. Sauter, 1998, The American journal of pathology.

Polysomies but not Y chromosome losses have prognostic significance in pTa/pT1 urinary bladder cancer.

H. Moch, G. Sauter, T. Gasser, 1999, Human pathology.

CDKNA2A mutation analysis, protein expression, and deletion mapping of chromosome 9p in conventional clear-cell renal carcinomas: evidence for a second tumor suppressor gene proximal to CDKN2A.

H. Moch, J. Kononen, G. Sauter, 2001, The American journal of pathology.

Allelic loss at the D9S171 locus on chromosome 9p13 is associated with progression of papillary renal cell carcinoma

H. Moch, G. Sauter, P. Schraml, 2000, The Journal of pathology.

Intratumoral heterogeneity of von Hippel-Lindau gene deletions in renal cell carcinoma detected by fluorescence in situ hybridization.

T C Gasser, H. Moch, L. Bubendorf, 1998, Cancer research.

Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings.

L. Bubendorf, G. Sauter, T. Gasser, 2001, American journal of clinical pathology.

Focal loss of CD44 variant protein expression is related to recurrence in superficial bladder carcinoma.

G. Sauter, T. Gasser, J. Roth, 1999, The American journal of pathology.

Short Communication Focal Loss of CD44 Variant Protein Expression is Related to Recurrence in Superficial Bladder Carcinoma

G. Sauter, D. Hauri, U. Schmid, 1999 .

Comparative genomic hybridization reveals frequent chromosome 13q and 4q losses in renal carcinomas with sarcomatoid transformation

H. Moch, G. Sauter, M. Mihatsch, 1998, The Journal of pathology.

Ki67 labeling index in core needle biopsies independently predicts tumor-specific survival in prostate cancer.

H. Moch, L. Bubendorf, G. Sauter, 1998, Human pathology.

Y chromosome loss detected by FISH in bladder cancer.

F. Waldman, H. Moch, G. Sauter, 1995, Cancer genetics and cytogenetics.

Prognostic significance of Bcl-2 in clinically localized prostate cancer.

H. Moch, L. Bubendorf, G. Sauter, 1996, The American journal of pathology.

High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer.

T Hardmeier, H. Moch, G. Sauter, 2001, Cancer research.

Chromosomal imbalances are associated with a high risk of progression in early invasive (pT1) urinary bladder cancer.

H. Moch, G. Sauter, T. Gasser, 1999, Cancer research.

p53 protein expression but not mdm-2 protein expression is associated with rapid tumor cell proliferation and prognosis in renal cell carcinoma

H. Moch, L. Bubendorf, G. Sauter, 2004, Urological Research.

Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa).

H. Moch, G. Sauter, T. Gasser, 1999, Cancer research.

Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization.

H. Moch, G. Sauter, T. Gasser, 1998, The American journal of pathology.

Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization.

H. Moch, G. Sauter, T. Gasser, 1997, Cancer research.

Reasons for discontinuing intracavernous injection therapy with prostaglandin E1 (alprostadil).

T. Gasser, A. Blöchlinger, K. Lehmann, 1999, Urology.

Discovery of new DNA amplification loci in prostate cancer by comparative genomic hybridization *

H. Moch, L. Bubendorf, G. Sauter, 2001, The Prostate.